22.06.2016 15:40 Uhr, Quelle: Engadget

CRISPR gene-editing approved for first human trials

A federal ethics and biosafety panel has approved the first ever human trials of the CRISPR-Cas9 gene editing technique. Researchers from the University of Pennsylvania aim to modify the immune system "T cells" in patients, helping them better fight

Weiterlesen bei Engadget